RIDZHENERON FARMAS JUTIKALZ INK has a total of 19 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Russian Federation. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ELUSYS THERAPEUTICS INC, IMMUGENICS AG and NVIP PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Russian Federation | 19 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Machines | |
#6 | Agriculture | |
#7 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Animal care | |
#6 | Syringes | |
#7 | Unspecified technologies | |
#8 | Microorganisms | |
#9 | Enzymes | |
#10 | Medical purpose containers |
# | Name | Total Patents |
---|---|---|
#1 | Martin Dzhoehl Kh | 7 |
#2 | Papadopulos Nikolas Dzh | 5 |
#3 | Stivens Shon | 5 |
#4 | Smit Ehrik | 4 |
#5 | Khuan Tammi T | 4 |
#6 | Makdonal D Linn | 3 |
#7 | Dehvis Sam Juehl | 3 |
#8 | Terston Gehvin | 3 |
#9 | Makdonald Duglas | 3 |
#10 | Nogera-Troise Irene | 2 |
Publication | Filing date | Title |
---|---|---|
RU2448979C2 | Human antibodies to delta-like human ligand-4 | |
RU2432155C2 | Vegf antagonist formulations suitable for intravitreal injections |